I Schillevoort

Summary

Affiliation: Utrecht University
Country: The Netherlands

Publications

  1. ncbi request reprint Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs
    I Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrect University, The Netherlands
    Eur J Clin Pharmacol 57:327-31. 2001
  2. ncbi request reprint Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine
    I Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, PO Box 80082, 3508 TB, Utrecht, The Netherlands
    Ann Pharmacother 35:1517-22. 2001
  3. ncbi request reprint Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports
    I Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
    Int Clin Psychopharmacol 17:75-9. 2002
  4. ncbi request reprint Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study
    Igor Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, The Netherlands
    Pharmacogenetics 12:235-40. 2002
  5. ncbi request reprint Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control study
    I Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Pharm World Sci 27:285-9. 2005
  6. ncbi request reprint Selective prescribing of atypical antipsychotics
    Nancy S Breekveldt-Postma
    PHARMO Institute, Institute for Pharmacology and Outcomes Research, Utrecht, The Netherlands
    Pharmacoepidemiol Drug Saf 14:25-30. 2005

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs
    I Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrect University, The Netherlands
    Eur J Clin Pharmacol 57:327-31. 2001
    ..We tried to replicate results from previous clinical trials that compared risperidone with high-potency APDs...
  2. ncbi request reprint Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine
    I Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, PO Box 80082, 3508 TB, Utrecht, The Netherlands
    Ann Pharmacother 35:1517-22. 2001
    ..To compare the risk of extrapyramidal syndrome (EPS) between risperidone, olanzapine, and haloperidol, taking into account patients' past antipsychotic drug use and past EPS...
  3. ncbi request reprint Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports
    I Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
    Int Clin Psychopharmacol 17:75-9. 2002
    ..However, those concurrently using antipsychotic drugs or presenting with other risk factors may be more susceptible and should be closely monitored...
  4. ncbi request reprint Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study
    Igor Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, The Netherlands
    Pharmacogenetics 12:235-40. 2002
    ..Poor metabolizers should have their antipsychotic drug dosage reduced when the metabolism of the prescribed drug depends on CYP2D6 activity or should receive an antipsychotic drug that is not CYP2D6-dependent...
  5. ncbi request reprint Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control study
    I Schillevoort
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Pharm World Sci 27:285-9. 2005
    ..While several clinical trials showed that atypical antipsychotics have a low risk of extrapyramidal side effects (EPS), this observation is not undisputed. This study compared the risk of EPS between specific subgroups of antipsychotics...
  6. ncbi request reprint Selective prescribing of atypical antipsychotics
    Nancy S Breekveldt-Postma
    PHARMO Institute, Institute for Pharmacology and Outcomes Research, Utrecht, The Netherlands
    Pharmacoepidemiol Drug Saf 14:25-30. 2005
    ....